Corroborating with this, an antagonist of GPR55, CID16020046, as well as GPR55−/− knockout mice decreased pro-inflammatory cytokines in mice models of colitis comparable to human inflammatory bowel disease (IBD) [12]. Here, GPR55 is linked to colitis.